AHA Coding Clinic® for HCPCS - 2023 Issue 1; For Your Information

Updated Emergency Use Authorizations for COVID-19 vaccines

The U.S. Food and Drug Administration (FDA) has authorized amended versions of its emergency use authorizations (EUA) for the administration of COVID-19 vaccines for the prevention of COVID-19 infection.Effective October 19, 2022, the FDA revised the EUA for the adjuvanted Novavax COVID-19 vaccine. The EUA for Novavax previously included a two-dose primary vaccine series for persons aged 12 and older. Now, the revised EUA authorizes a first booster dose for patients 18 years and older, that are at least 6 months out from completion of a primary vaccination series with an authorized or approved COVID-19 vaccine, for...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.

Thank you for choosing Find-A-Code, please Sign In to remove ads.